A novel role for IκB kinase (IKK) α and IKKβ in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae

Journal of Immunology

Volumn 178, Issue 3, 2007, Pages 1736-1747

  Ha, Unhwan ^a,b   Lim, Jae Hyang ^a,b   Jono, Hirofumi ^a,b   Koga, Tomoaki ^a,b   Srivastava, Amit ^c   Malley, Richard ^c   Pagès, Gilles ^d   Pouysségur, Jacques ^d   Li, Jian Dong ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CENTRE DE BIOCHIMIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MUCIN 5AC; PNEUMOLYSIN; PROTEIN P100; PROTEIN P52; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 4; BACTERIAL PROTEIN; I KAPPA B KINASE; MUCIN; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; STREPTOLYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; MUCOCILIARY CLEARANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; STREPTOCOCCUS PNEUMONIAE; TRANSCRIPTION REGULATION; ANIMAL; BRONCHUS; CELL CULTURE; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; UPREGULATION;

ANIMALS; BACTERIAL PROTEINS; BRONCHI; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; I-KAPPA B KINASE; IMMUNITY, NATURAL; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUCINS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 33846518459     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.3.1736     Document Type: Article

References (63)

1. Kopp, E., and R. Medzhitov. 2003. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15: 396-401.
2. Rose, M. C., and J. A. Voynow. 2006. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol. Rev. 86: 245-278.
3. Knowles, M. R., and R. C. Boucher. 2002. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 109: 571-577.
4. Rose, M. C., T. J. Nickola, and J. A. Voynow. 2001. Airway mucus obstruction: mucin glycoproteins, MUC gene regulation and goblet cell hyperplasia. Am. J. Respir. Cell Mol. Biol. 25: 533-537.
5. Caramori, G., C. Di Gregorio, I. Carlstedt, P. Casolari, I. Guzzinati, I. M. Adcock, P. J. Barnes, A. Ciaccia, G. Cavallesco, K. F. Chung, and A. Papi. 2004. Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease. Histopathology 45: 477-484.
6. Kim, W. D. 1997. Lung mucus: a clinician's view. Eur. Respir. J. 10: 1914-1917.
7. Carrie, S., D. A. Hutton, J. P. Birchall, G. G. Green, and J. P. Pearson. 1992. Otitis media with effusion: components which contribute to the viscous properties. Acta Otolaryngol. 112: 504-511.
8. Majima, Y., Y. Hamaguchi, K. Hirata, K. Takeuchi, A. Morishita, and Y. Sakakura. 1988. Hearing impairment in relation to viscoelasticity of middle ear effusions in children. Ann. Otol. Rhinol. Laryngol. 97: 272-274.
9. Klugman, K. P., and C. Feldman. 2001. Streptococcus pneumoniae respiratory tract infections. Curr. Opin. Infect. Dis. 14: 173-179.
10. Bluestone, C. D., J. S. Stephenson, and L. M. Martin. 1992. Ten-year review of otitis media pathogens. Pediatr. Infect. Dis. J. 11: S7-S11.
11. Berry, A. M., A. D. Ogunniyi, D. C. Miller, and J. C. Paton. 1999. Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene. Infect. Immun. 67: 981-985.
12. Paton, J. C., A. M. Berry, and R. A. Lock. 1997. Molecular analysis of putative pneumococcal virulence proteins. Microb. Drug. Resist. 3: 1-10.
13. Berry, A. M., J. Yother, D. E. Briles, D. Hansman, and J. C. Paton. 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57: 2037-2042.
14. Benton, K. A., M. P. Everson, and D. E. Briles. 1995. A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect. Immun. 63: 448-455.
15. Wheeler, J., R. Freeman, M. Steward, K. Henderson, M. J. Lee, N. H. Piggott, G. J. Eltringham, and A. Galloway. 1999. Detection of pneumolysin in sputum. J. Med. Microbiol. 48: 863-866.
16. Gilbert, R. J., J. L. Jimenez, S. Chen, I. J. Tickle, J. Rossjohn, M. Parker, P. W. Andrew, and H. R. Saibil. 1999. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 97: 647-655.
17. Mitchell, T. J., P. W. Andrew, F. K. Saunders, A. N. Smith, and G. J. Boulnois. 1991. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol. Microbiol. 5: 1883-1888.
18. Cockeran, R., A. J. Theron, H. C. Steel, N. M. Matlola, T. J. Mitchell, C. Feldman, and R. Anderson. 2001. Proinflammatory interactions of pneumolysin with human neutrophils. J. Infect. Dis. 183: 604-611.
19. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263.
20. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
21. Bonizzi, G., and M. Karin. 2004. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25: 280-288.
22. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-κB. Genes Dev. 18: 2195-2224.
23. Avery, O. T., C. M. MacLeod, and M. McCarty. 1979. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: inductions of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J. Exp. Med. 149: 297-326.
24. Briles, D. E., M. J. Crain, B. M. Gray, C. Forman, and J. Yother. 1992. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect. Immun. 60: 111-116.
25. Srivastava, A., P. Henneke, A. Visintin, S. C. Morse, V. Martin, C. Watkins, J. C. Paton, M. R. Wessels, D. T. Golenbock, and R. Malley. 2005. The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect. Immun. 73: 6479-6487.
26. Li, Q., Q. Lu, J. Y. Hwang, D. Buscher, K. F. Lee, J. C. Izpisua-Belmonte, and I. M. Verma. 1999. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13: 1322-1328.
27. Li, Q., G. Estepa, S. Memet, A. Israel, and I. M. Verma. 2000. Complete lack of NF-κB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes Dev. 14: 1729-1733.
28. Yang, F., E. Tang, K. Guan, and C. Y. Wang. 2003. IKK β plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J. Immunol. 170: 5630-5635.
29. Chun, Y. M., S. K. Moon, H. Y. Lee, P. Webster, D. E. Brackmann, J. S. Rhim, and D. J. Lim. 2002. Immortalization of normal adult human middle ear epithelial cells using a retrovirus containing the E6/E7 genes of human papillomavirus type 16. Ann. Otol. Rhinol. Laryngol. 111: 507-517.
30. Kim, S., A. J. Schein, and J. A. Nadel. 2005. E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells. Am. J. Physiol. 289: L1049-L1060.
31. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284-288.
32. Yoshida, H., H. Jono, H. Kai, and J. D. Li. 2005. The tumor suppressor cylin-dromatosis (CYLD) acts as a negative regulator for Toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. J. Biol. Chem. 280: 41111-41121.
33. Watanabe, T., H. Jono, J. Han, D. J. Lim, and J. D. Li. 2004. Synergistic activation of NF-κB by nontypeable Haemophilus influenzae and tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 101: 3563-3568.
34. Jono, H., H. Xu, H. Kai, D. J. Lim, Y. S. Kim, X. H. Feng, and J. D. Li. 2003. Transforming growth factor-β-Smad signaling pathway negatively regulates non-typeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1- dependent inhibition of p38 MAPK. J. Biol. Chem. 278: 27811-27819.
35. Shuto, T., H. Xu, B. Wang, J. Han, H. Kai, X. X. Gu, T. F. Murphy, D. J. Lim, and J. D. Li. 2001. Activation of NF-κB by nontypeable Haemophilus influenzae is mediated by Toll-like receptor 2-TAK1-dependent NIK-IKK α/β-I kappa B α and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc. Natl. Acad. Sci. USA 98: 8774-8779.
36. Jono, H., T. Shuto, H. Xu, H. Kai, D. J. Lim, J. R. Gum, Jr., Y. S. Kim, S. Yamaoka, X. H. Feng, and J. D. Li. 2002. Transforming growth factor-β-Smad signaling pathway cooperates with NF-κB to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription. J. Biol. Chem. 277: 45547-45557.
37. Chen, R., J. H. Lim, H. Jono, X. X. Gu, Y. S. Kim, C. B. Basbaum, T. F. Murphy, and J. D. Li. 2004. Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKβ-IκBα-NF-κB signaling pathways. Biochem. Biophys. Res. Commun. 324: 1087-1094.
38. Li, D., M. Gallup, N. Fan, D. E. Szymkowski, and C. B. Basbaum. 1998. Cloning of the amino-terminal and 5′-flanking region of the human MUC5AC mucin gene and transcriptional upregulation by bacterial exoproducts. J. Biol. Chem. 273: 6812-6820.
39. Trompouki, E., E. Hatzivassiliou, T. Tsichritzis, H. Farmer, A. Ashworth, and G. Mosialos. 2003. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 424: 793-796.
40. Burgel, P. R., S. C. Lazarus, D. C. Tam, I. F. Ueki, K. Atabai, M. Birch, and J. A. Nadel. 2001. Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor receptor activation. J. Immunol. 167: 5948-5954.
41. Pages, G., S. Guerin, D. Grall, F. Bonino, A. Smith, F. Anjuere, P. Auberger, and J. Pouyssegur. 1999. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286: 1374-1377.
42. Braun, J. S., R. Novak, G. Gao, P. J. Murray, and J. L. Shenep. 1999. Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect. Immun. 67: 3750-3756.
43. Malley, R., P. Henneke, S. C. Morse, M. J. Cieslewicz, M. Lipsitch, C. M. Thompson, E. Kurt-Jones, J. C. Paton, M. R. Wessels, and D. T. Golenbock. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA 100: 1966-1971.
44. van Rossum, A. M., E. S. Lysenko, and J. N. Weiser. 2005. Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect. Immun. 73: 7718-7726.
45. Schmeck, B., S. Huber, K. Moog, J. Zahlten, A. C. Hocke, B. Opitz, S. Hammerschmidt, T. J. Mitchell, M. Kracht, S. Rosseau, et al. 2006. Pneumococci induced TLR- and Rac1-dependent NF-κB-recruitment to the IL-8 promoter in lung epithelial cells. Am. J. Physiol. 290: L730-L737.
46. Garrington, T. P., and G. L. Johnson. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11: 211-218.
47. Wang, B., D. J. Lim, J. Han, Y. S. Kim, C. B. Basbaum, and J. D. Li. 2002. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J. Biol. Chem. 277: 949-957.
48. Vaudry, D., P. J. Stork, P. Lazarovici, and L. E. Eiden. 2002. Signaling pathways for PC12 cell differentiation: making the right connections. Science 296: 1648-1649.
49. Gotoh, Y., E. Nishida, T. Yamashita, M. Hoshi, M. Kawakami, and H. Sakai. 1990. Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells: identity with the mitogen-activated MAP kinase of fibroblastic cells. Eur. J. Biochem. 193: 661-669.
50. Li, Q., and I. M. Verma. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2: 725-734.
51. Neish, A. S., A. T. Gewirtz, H. Zeng, A. N. Young, M. E. Hobert, V. Karmali, A. S. Rao, and J. L. Madara. 2000. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 289: 1560-1563.
52. Ratner, A. J., K. R. Hippe, J. L. Aguilar, M. H. Bender, A. L. Nelson, and J. N. Weiser. 2006. Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J. Biol. Chem. 281: 12994-12998.
53. Waterfield, M., W. Jin, W. Reiley, M. Zhang, and S. C. Sun. 2004. IκB kinase is an essential component of the Tpl2 signaling pathway. Mol. Cell Biol. 24: 6040-6048.
54. Betake, S., M. J. Robinson, M. Hugunin, and S. C. Ley. 2004. Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IκB kinase-induced proteolysis of NF-κB1 p105. Mol. Cell Biol. 24: 9658-9667.
55. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
56. Traverse, S., N. Gomez, H. Paterson, C. Marshall, and P. Cohen. 1992. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells: comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288: 351-355.
57. Nguyen, T. T., J. C. Scimeca, C. Filloux, P. Peraldi, J. L. Carpentier, and E. Van Obberghen. 1993. Co-regulation of the mitogen-activated protein kinase, extracellular signal-regulated kinase 1, and the 90-kDa ribosomal S6 kinase in PC12 cells: distinct effects of the neurotrophic factor, nerve growth factor, and the mitogenic factor, epidermal growth factor. J. Biol. Chem. 268: 9803-9810.
58. Mitchell, T. J., and P. W. Andrew. 1997. Biological properties of pneumolysin. Microb. Drug Resist. 3: 19-26.
59. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
60. Henderson, B., and M. Wilson. 1996. Cytokine induction by bacteria: beyond lipopolysaccharide. Cytokine 8: 269-282.
61. Rubins, J. B., P. G. Duane, D. Charboneau, and E. N. Janoff. 1992. Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect. Immun. 60: 1740-1746.
62. Rubins, J. B., P. G. Duane, D. Clawson, D. Charboneau, J. Young, and D. E. Niewoehner. 1993. Toxicity of pneumolysin to pulmonary alveolar epithelial cells. Infect. Immun. 61: 1352-1358.
63. Rubins, J. B., D. Charboneau, J. C. Paton, T. J. Mitchell, P. W. Andrew, and E. N. Janoff. 1995. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J. Clin. Invest. 95: 142-150.